Register
Question 1
Which hormone primarily influences the increase of VMS symptoms during menopause?
Correct Answer:
Estrogen
Explanation:
Estrogen is the primary hormone that influences the increase of vasomotor symptoms (VMS) during menopause, which are characterized by hot flashes and night sweats. As women approach menopause, the levels of estrogen fluctuate and eventually decline significantly. This reduction in estrogen is directly related to the onset and intensity of VMS symptoms. Estrogen plays a crucial role in regulating the body's temperature control center, which is located in the hypothalamus. When estrogen levels drop, this center becomes more sensitive to changes in body temperature, leading to the thermoregulatory disturbances that manifest as hot flashes and night sweats. While other hormones like testosterone, estradiol (which is a form of estrogen), and progesterone also play roles in women's health, they do not have the same direct impact on VMS as estrogen does. Estradiol is a form of estrogen, so while it is important, the general category of estrogen is more indicative of the hormone's influence on VMS symptoms during menopause. Similarly, testosterone and progesterone are less involved in the management of VMS specifically. Therefore, understanding the significance of estrogen is essential in addressing VMS during menopause.
Question 2
In the first year after the final menstrual period (FMP), what hormone is absent?
Correct Answer:
Progesterone
Explanation:
In the first year after the final menstrual period (FMP), the hormone that is absent is progesterone. This absence is primarily due to the cessation of ovarian activity that accompanies menopause, marking the end of a woman's reproductive years. Progesterone plays a crucial role in the menstrual cycle, particularly in the regulation of the second half of the cycle after ovulation. During this phase, if an egg is not fertilized, progesterone levels drop, leading to menstruation. After menopause, with the ovaries no longer releasing eggs, there is a significant decrease in progesterone production. Consequently, women may experience symptoms commonly associated with menopause, such as hot flashes, night sweats, and mood changes, as the hormonal landscape shifts dramatically. Knowledge of the hormonal changes during menopause is key for understanding the biological processes at play, which helps inform therapeutic approaches for managing menopause-related symptoms.
Question 3
When can progesterone be added in the treatment of estradiol for women with an intact uterus?
Correct Answer:
For 12 days of the month
Explanation:
When a woman has a uterus and is taking estrogen, adding progesterone is essential to protect the endometrium from unopposed estrogen stimulation. Estrogen alone can cause the uterine lining to grow, which over time raises the risk of endometrial hyperplasia and cancer. Progesterone counteracts this by promoting secretory changes and eventual shedding, preventing prolonged buildup. In practice, the common cyclic approach is to give progesterone for a limited window each month, typically about 12 days. This creates a predictable withdrawal bleed and provides endometrial protection while allowing estrogen to manage symptoms like hot flashes during the rest of the month. Other options don’t fit this context well: hot flashes don’t dictate the need for progesterone, and while some regimens use continuous combined therapy (progesterone every day with estrogen), the standard teaching reflected here emphasizes a 12-day, cyclic addition. Progesterone isn’t added only when estrogen levels are high; protection is needed whenever estrogen is used in someone with a uterus.
Question 4
What should be done for patients diagnosed with high-grade VIN?
Correct Answer:
Wide local excision
Explanation:
For patients diagnosed with high-grade vulvar intraepithelial neoplasia (VIN), the most appropriate approach is a wide local excision. This method is aimed at completely removing the lesions to reduce the risk of progression to invasive cancer. High-grade VIN is considered a precancerous condition, which warrants a more aggressive treatment strategy compared to low-grade lesions. Wide local excision allows for both diagnosis and treatment, ensuring that any potentially malignant cells are removed. This approach not only addresses the immediate health concern but also alleviates the anxiety surrounding potential progression to vulvar carcinoma. Other treatment options, such as laser therapy, may be applicable in certain cases but are not typically the first line for high-grade VIN, which necessitates ensuring the lesion's complete removal. Monitoring without treatment is inappropriate for high-grade VIN due to the increased likelihood of progression to cancer. Topical steroids are not effective in treating high-grade VIN lesions and do not offer the necessary intervention required for this serious diagnosis.
Question 5
Which dietary change is beneficial for menopausal women?
Correct Answer:
Increasing intake of fruits, vegetables, and whole grains
Explanation:
Increasing intake of fruits, vegetables, and whole grains is highly beneficial for menopausal women due to several key factors. During menopause, hormonal changes can lead to various symptoms such as hot flashes, mood swings, and weight gain. A diet rich in fruits and vegetables provides essential vitamins and minerals that can alleviate some of these symptoms and promote overall health. Fruits and vegetables are also high in antioxidants, which help combat oxidative stress—a condition that has been linked to menopausal symptoms and various chronic diseases. Additionally, incorporating whole grains into the diet can aid in maintaining a healthy weight and support digestive health due to their high fiber content. Adequate fiber intake is crucial during menopause as it can help mitigate weight gain and reduce the risk of developing conditions like heart disease, which can increase after menopause. This dietary approach aligns with recommendations for maintaining a balanced diet that supports not just menopausal health but overall well-being. In contrast, increasing saturated fats, reducing fruit and vegetable consumption, or limiting fiber would contradict these health benefits and potentially exacerbate menopausal symptoms or worsen health outcomes.
Question 1
Exam overview

About this Exam

The NAMS Menopause Certification Exam is the definitive pathway to the Menopause Society Certified Practitioner (MSCP) credential, formerly known as the NAMS Certified Menopause Practitioner (NCMP). This prestigious certification, offered by The Menopause Society (formerly the North American Menopause Society, or NAMS), validates your expertise in managing the care of women throughout the menopause transition and beyond.


This exam is designed specifically for licensed healthcare providers, including physicians (MD/DO), nurse practitioners (NPs), physician assistants (PAs), pharmacists (PharmD), and other qualified clinicians who are dedicated to providing evidence-based, specialized care to the midlife female population. Achieving the MSCP credential signals to patients, peers, and employers that you have met a rigorous national standard of knowledge in menopausal health.

More details

Additional Information

 What the Course Entails and Exam Details

This is a comprehensive, competency-based examination, not a course with a mandated syllabus. To prepare, clinicians are expected to have a deep, practical understanding of midlife women's health derived from clinical experience and independent study. The exam is derived from a detailed blueprint based on five major domains of knowledge.

The exam covers the following core content areas with specific weighting:

  • Physiology and Pathophysiology of the Menopause Transition (19%): Including reproductive aging stages (e.g., STRAW+10), hormonal changes (FSH, estrogen, progesterone), and the impact of abrupt estrogen loss.
  • Symptoms and Concerns (20%): Diagnosis and evaluation of vasomotor symptoms (VMS), genitourinary syndrome of menopause (GSM), mood changes, sleep disruption, and sexual health issues.
  • Health Disorders in Midlife (21%): Management and screening for age- and menopause-related health issues, such as osteoporosis, cardiovascular disease risk, diabetes, and cancers.
  • Treatment Options for Common Menopause Symptoms (16%): Evidence-based application of hormonal therapies (HT, MHT) and non-hormonal management options (lifestyle, CBT, pharmaceuticals) for symptom relief.
  • Preventive Care and Counseling (19%): Long-term health maintenance, counseling candidates on HT decision-making, monitoring, and non-hormonal strategies for long-term well-being.

 

 

 What to Expect in the Final Exam

The final exam is a computer-based, comprehensive test. It is highly analytical, requiring the application of knowledge to clinical scenarios, not merely recall of facts. Candidates can expect a high level of clinical rigor.

The specific exam details are:

  • Exam Format: The test consists of 100 multiple-choice questions. Each question typically offers three options (A, B, or C).
  • Time Limit: Candidates are given two hours to complete the entire examination.
  • Passing Score Requirements: To pass, candidates must achieve a scaled score of at least 75 (out of a scaled range of 0 to 99). Note that scaled scores are calculated to maintain difficulty across different exam forms.
  • Rules: Standard testing protocols are enforced. No study materials or aids are allowed in the testing area. Candidates must register and provide proof of their active, unrestricted clinical license to practice.

 

 

 How to Study and Exam Centers

Preparation for the NAMS Menopause Certification Exam requires a multi-faceted approach, combining foundational medical knowledge with specific, current guidelines.

Actionable Study Strategies:

Download the Candidate Handbook: This is your critical roadmap. It contains the official exam blueprint, a list of suggested resources, and important dates.

Study Official NAMS Resources: The primary texts to master are The Menopause Society’s own resources, including The Menopause Practice: A Clinician’s Guide and current Position Statements on hormone therapy and related topics.

Complete CE in Menopause Care: Participate in relevant Continuing Education courses and attend The Menopause Society Annual Meetings. These provide evidence-based updates and clinical insights that align with the exam.

Use Practice Exams: A practice exam, featuring NAMS Menopause Certification Practice Exam questions, is an invaluable tool. Use these to familiarize yourself with the three-option multiple-choice format and to assess your timing. Analyze both correct and incorrect answers to understand the clinical rationale behind each.

Where and How to Take the Exam:

The exam is administered exclusively as a computer-based test at specific test centers. The NAMS Menopause Society utilizes a reputable, standardized testing service for administration.

To register and schedule your exam:

  • Online Portal: All applications, license verifications, and fee payments must be completed through The Menopause Society's official website (menopause.org) during the designated open registration windows.
  • Testing Centers: After successful registration, you will receive instructions on how to schedule your examination time and select a convenient location through the certified testing vendor’s network of physical testing centers, which offers multiple locations across North America and potentially internationally.

 

 

Job Opportunities from the Course

Achieving the MSCP credential directly unlocks advanced career paths and specialized job opportunities. It validates your competency to act as the primary menopause resource within a healthcare system or a private practice.

Specific job titles and career paths this certification can unlock include:

  • Menopause Society Certified Practitioner (MSCP) within:
    • Primary Care/Family Medicine Practices
    • Obstetrics and Gynecology (OB/GYN) Practices
    • Endocrinology Clinics
    • Internal Medicine Practices
    • Fertility and Reproductive Endocrinology Clinics
  • Midlife Women’s Health Program Director
  • Menopause Telehealth Specialist / Remote Clinician
  • Medical Science Liaison (MSL) specializing in Women’s Health for pharmaceutical or medical device companies
  • Clinical Educator / Faculty Member focusing on midlife women’s health
  • Consulting Pharmacist (with NCMP/MSCP for PharmDs) specializing in midlife hormone management
Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

2026 FFM Agent Broker Certification Practice Exam

0 min

3CX Academy Advanced Certification Practice Exam

0 min

3CX Academy Basic Certification Practice Exam

0 min

3CX Intermediate Certification Practice Exam

0 min

Ultimate Study Guide for the Argus Certification Practice Test

0 min

Arizona Caregiver Certification Practice Exam

0 min